Beyond the effect on tumor intrinsic pro-inflammatory pathways, a series of recent investigations demonstrate the involvement of DNA methylation in regulating the expressions of multiple immune checkpoint molecules like PD-L1, PD-L2, CTLA-4, LAG3, TIM-3, and Galectin-9. This evidence concerns the gene CTLA4 and neoplasm.